<DOC>
	<DOC>NCT01904045</DOC>
	<brief_summary>Aim of this study is to investigate whether in patients following kidney transplantation (&gt;6 months after transplantation), the intra-patient variability of levels of tacrolimus is comparable after administration of tacrolimus twice daily (Prograf) to tacrolimus once daily (Advagraf), with each regimen for 3 months.</brief_summary>
	<brief_title>PEL-1235_REN-0176-I</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>signed written informed consent male or female patient â‰¥ 18years of age Patient has received a kidney transplantation at least 6 months prior to inclusion into the study No acute rejection episodes for at least 3 months PRG through level and dosing stable for at least 1 month Patient is capable of understanding the purpose and risks of the study, has been fully informed and has given written informed consent to participate in the study Acute rejection episodes within the last 3 months prior to study entry Unstable PRG trough level or dose change in the month before study entry History of noncompliance to medical regimens Patients unwilling to or unable to comply with the protocol Treatment with another investigational product during this study or during the last 30 days prior to study start</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>